You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. ZEAMATIN: A POSSIBLE HUMAN THERAPEUTIC ANTIFUNGAL AGENT

    SBC: MycoTox, Inc.            Topic: N/A

    A 22-KDA PROTEIN THAT HAS POTENT ACTIVITY AGAINST A NUMBER OF CLINICALLY IMPORTANT HUMAN PATHOGENS HAS BEEN ISOLATED FROM MAIZE SEEDS. IN ADDITION, THIS PROTEIN, NAMED ZEAMATIN, HAS THE UNIQUE ABILITY TO SYNERGIZE WITH KNOWN ANTIFUNGAL DRUGS, DECREASING THE DOSE REQUIRED FOR FUNGAL CELL KILLING WHILE INCREASING THE SPECTRUM OF ACTIVITY. AS A PRELUDE TO IN VIVO TESTING, IT IS PLANNED TO DETERMINE T ...

    SBIR Phase I 1990 Department of Health and Human Services
  2. ZEAMATIN, AN ANTIFUNGAL THERAPEUTIC

    SBC: MycoTox, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  3. VIRTUAL REALITY-BASED ANGIOPLASTY SIMULATOR

    SBC: Image Medical Communications            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  4. VACCINE POTENTIAL OF TOXOPLASMA GONDII RECOMBINANT P3

    SBC: Paravax Inc.            Topic: N/A

    P30, THE MAJOR SURFACE ANTIGEN OF THE TOXOPLASMA GONDII TACHYZOITE STAGE, HAS BEEN ISOLATED FROM THE PARASITE AND SHOWN TO PROTECT MICE FROM A VIRULENT T. GONDII CHALLENGE. THE CDNA ENCODING P30 HAD BEEN CLONED AND EXPRESSED IN E. COLI, PRODUCING RECOMBINANT PROTEIN THAT WAS POORLY RECOGNIZED BY ANTIBODY TO NATIVE PROTEIN. THE SPECIFIC AIM OF THIS PROJECT IS TO DEMONSTRATE THAT RECOMBINANT P30 CAN ...

    SBIR Phase II 1993 Department of Health and Human Services
  5. VACCINE POTENTIAL OF TOXOPLASMA GONDII RECOMBINANT P3

    SBC: Paravax Inc.            Topic: N/A

    N/A

    SBIR Phase I 1991 Department of Health and Human Services
  6. UV/Visible Video-Rate Confocal Microscope

    SBC: Meridian Instruments, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1993 Department of Health and Human Services
  7. UV DETECTOR FOR GENERAL USE FOR SKIN CANCER PREVENTION

    SBC: Solartech Enterprises, Llc            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  8. USE OF ANTIBODIES TO MODIFIED ALPHA 1 ANTICHYMOTRYPSIN

    SBC: Athens Research And Technology            Topic: N/A

    ALZHEIMER'S DISEASE (AD), A LEADING HEALTH PROBLEM FOR THIS COUNTRY, AFFECTS 5 TO L0 PERCENT OF THOSE OVER 65. BY THE YEAR 2000, THIS AGING POPULATION WILL DOUBLE. A TEST PERMITTING A DEFINITIVE AND EARLY DIAGNOSIS OF AD IS GREATLY NEEDED. WE SEEK TO DEVELOP SUCH A DIAGNOSTIC TEST USING MABS IT HAS RAISED TO A MODIFIED FORM OF ALX. IN PHASE I STUDY, ART WILL CHARACTERIZE ITS MABS, DESIGN A PILOT I ...

    SBIR Phase I 1991 Department of Health and Human Services
  9. USE OF A CCD CAMERA FOR LOW-COST CONFOCAL MICROSCOPY

    SBC: Meridian Instruments, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1991 Department of Health and Human Services
  10. Ultraviolet B Irradiation of Allogeneic Veins

    SBC: CRYOLIFE, INC.            Topic: N/A

    The major factor limiting more widespread utilization of allogeneic veins in arterial bypass procedures is the recipients' immune response. The intimal endothelial cells appear to be the focus of this immune response, which results in loss of the intimal lining of the vessel lumen during the first two weeks after transplantation and the longer-term risk of occlusion. This proposal will examine the ...

    SBIR Phase I 1993 Department of Health and Human Services
US Flag An Official Website of the United States Government